Cranial Orthoses - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The cranial orthoses market size is projected to expand from USD 0.38 billion in 2025 and USD 0.42 billion in 2026 to USD 0.66 billion by 2031, registering a CAGR of 9.53% between 2026 to 2031. This report is segmented by Product Type (Active, Passive, Custom-Molded), Application (Plagiocephaly, Brachycephaly, Scaphocephaly, Postsurgical), Material (Thermoplastic, PE Foam, PU Foam, Copolymer, Silicone), Patient Age (Below 3, 3-6, 7-12, 13-18, Above 18 Months), End User (Hospitals, Pediatric Centers, O&P Clinics, Others), and Geography (North America, Europe, and More). Value (USD).

Global Cranial Orthoses Market Trends and Insights

Rising Diagnosis of Positional Plagiocephaly

Rising diagnoses of plagiocephaly and brachycephaly remain a key driver of the cranial orthoses market, as diagnosis initiates clinical monitoring, referral, fitting, and follow-up. A 2024 population-based study reported incidence rates of 5.8% in term infants and 11.8% in preterm infants, highlighting preterm birth as a significant risk factor. A 2026 study of 2,165 preterm infants in Beijing found postural cranial abnormalities in 81.2% of infants aged 0-2 months, the highest rate among the reviewed age groups. These findings emphasize the need for early head-shape monitoring, conservative repositioning, clinical observation, and timely referral during the preferred 3-8-month treatment window. Effective screening, parent education, clinician awareness, and referral pathways can reduce treatment delays and support market demand.

Growing Pediatric Referral and Early-Intervention Rates

Organized referral pathways are improving treatment access after diagnosis, particularly when assessment and fitting are integrated within the same clinical system. Shriners Children’s New England launched a cranial remolding program in May 2025 that integrated 3D scanning into its orthotics workflow and enabled families to complete scanning and fitting in a single visit. This model reduces handoffs among pediatricians, specialists, orthotists, families, and payers, which can otherwise delay care. Hospital-based services also simplify referrals by providing orthotists and pediatric specialists within the same setting. Greater awareness of early treatment windows supports timely intervention and demand in the cranial orthoses market.

Clinical Debate Over Incremental Benefit in Moderate Cases

Clinical disagreement over moderate plagiocephaly treatment can delay referrals in the cranial orthoses market, particularly when clinicians and payers prioritize conservative management. A systematic review covering January 2015 to January 2025 reported monthly correction rates of 0.66 for helmet-treated infants and 0.64 for conservatively managed infants. While 25% of helmet-treated cases reached severity level 1, compared with 11% of conservatively managed cases, the difference was not statistically significant across the available trial pool. Concerns regarding skin irritation, infant compliance, and caregiver burden further reduce treatment conversion among diagnosed moderate cases, limiting the market’s addressable volume.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of 3D Scanning and Digital Customization
• Improving Reimbursement and Prior-Authorization Pathways
• Inconsistent Payer Coverage and Documentation Requirements

Segment Analysis

Active helmets held 56.45% of the cranial orthoses market share in 2025, supported by established clearance histories, long-term clinical use, and proprietary digital scanning systems embedded in treatment networks. Cranial Technologies’ DOC Band uses Digital Surface Imaging to capture a complete 3D head model in less than 1 second and guide growth-room placement within its modified polyethylene foam interior. This workflow supports consistent fitting and follow-up while maintaining the active correction approach. A 10-year review of 27,990 treated infants reported a mean cranial vault asymmetry index reduction of 3.42 percentage points, with 87.6% of patients improving by at least one severity category.

Passive helmets are forecast to grow at a CAGR of 12.87% through 2031 as providers in cost-sensitive and emerging settings adopt thermoplastic designs requiring lower scanning investment and simpler production infrastructure. Active and passive designs address different clinical workflows and provider investment levels. Custom-molded orthoses retain a specialized role after craniosynostosis surgery, where individualized geometry is required. Pre-fabricated protective variants serve areas with limited therapeutic cranial remolding services, enabling the market to address both advanced digital clinics and resource-constrained settings.

Plagiocephaly accounted for 54.34% of the cranial orthoses market size in 2025, reflecting its position as the most common treatment indication and sustained diagnostic prevalence after the Back to Sleep campaign. Screening at 2-month and 4-month well-child visits directs a significant share of diagnosed infants into plagiocephaly-specific treatment pathways before age reduces correction potential. Although referral timing and quality vary across healthcare systems, early identification supports predictable patient volumes. Plagiocephaly therefore remains the primary application supporting the cranial orthoses market.

Brachycephaly is forecast to grow at a CAGR of 11.56% through 2031, driven by increased recognition during routine assessments. The 2026 Beijing study found that brachycephaly detection increased from 9.0% in the 3-4 months cohort to 19.8% in the 5-6 months cohort. Scaphocephaly requires specialized postsurgical fitting after premature sagittal suture fusion, and 2025 Hanger Institute research provided standardized craniometric indices for patient assessment. Postsurgical cranial deformity remains lower in volume but higher in value because helmet use is integrated into the surgical care episode and generally receives coverage.

Complete Report Scope:

• By Product Type
  • Active Helmets
  • Passive Helmets
  • Custom-Molded Orthoses
  • Other Product Types
• By Application
  • Plagiocephaly
  • Brachycephaly
  • Scaphocephaly
  • Postsurgical Cranial Deformity
• By Material
  • Thermoplastic Outer Shells
  • Polyethylene Foam Interfaces
  • Polyurethane Foam Interfaces
  • Copolymer Materials
  • Silicone and Soft-Interface Materials
• By Patient Age
  • Below 3 Months
  • 3-6 Months
  • Above 7-12 Months
  • Above 13-18 Months
  • Above 18 Months
• By End User
  • Hospitals
  • Pediatric and Craniofacial Centers
  • Orthotic and Prosthetic Clinics
  • Neurosurgery and Craniofacial Surgery Clinics
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 39.56% of revenue in 2025, supported by a mature pediatric care system, a broad orthotist base, and hospital-embedded 3D scanning services. The United States drove regional demand through established specialist networks and gradually expanding reimbursement access. Texas enacted HB 426 in June 2025, requiring Medicaid and CHIP coverage for cranial remolding orthoses for infants with plagiocephaly from September 2025, while North Carolina Medicaid revised Clinical Coverage Policy 5B in September 2024. More than 40% of US counties lacked access to an American Cleft Palate and Craniofacial Association-approved team within 100 miles, supporting demand for mobile scanning and remote follow-up services. Canada provides coverage in most provinces, while Mexico remains a smaller market due to lower healthcare spending and limited specialist infrastructure.

Asia-Pacific is forecast to grow at a CAGR of 12.98% through 2031, more than 3 percentage points above the global rate, driven by clinical demand and expanding institutional capacity. A Japanese study found positional plagiocephaly in 57.4% of infants aged 2-23 months, while a 2026 Beijing study of 2,165 preterm infants found postural cranial abnormalities in 81.2% of infants aged 0-2 months. KKH Singapore launched the region’s first dedicated PlagioCentre in June 2025 and selected Japan Medical Company’s Qurum Fit helmet through a competitive process.

Europe benefits from established pediatric healthcare systems and an EU MDR documentation framework that increases clinical evidence and recordkeeping requirements for cranial remolding devices. Germany, the United Kingdom, and France are the region’s largest national markets, supported by reimbursement systems with defined medical-necessity criteria. These conditions favor providers with strong documentation capabilities and make it more difficult for low-cost imports to compete solely on price.

List of Companies Covered in this Report:

• Boston Orthotics & Prosthetics
• Cranial Center of Utah
• Cranial Kids
• Cranial Remolding Orthosis, LLC
• Cranial Technologies, Inc.
• Danmar Products, Inc.
• Hanger, Inc.
• Invent Medical Group
• Ktwo Healthcare Pvt. Ltd.
• Level 4 Prosthetics and Orthotics
• Orthomerica Products, Inc.
• Orthotic & Prosthetic Lab, Inc.
• Orthotic Care Services, LLP
• Ottobock
• SHINING 3D
• SPS Co.
• STAR Cranial Center
• Stryker
• Surestep, LLC
• Yakima Orthotics & Prosthetics

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support